These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 15518742
1. Sirolimus (rapamycin) reduces the incidence of acute rejection episodes in renal transplantation: an initial experience in Taiwan. Liu KL, Chu SH, Chiang YJ, Wu CT, Chen Y. Transplant Proc; 2004 Sep; 36(7):2051-2. PubMed ID: 15518742 [Abstract] [Full Text] [Related]
2. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation. Knight RJ, Kerman RH, Zela S, Podder H, Van Buren CT, Katz S, Kahan BD. Transplantation; 2003 Apr 27; 75(8):1301-6. PubMed ID: 12717220 [Abstract] [Full Text] [Related]
3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T. Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109 [Abstract] [Full Text] [Related]
4. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398 [Abstract] [Full Text] [Related]
5. Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab. Alexandru S, Gonzalez E, Grande C, Hernandez A, Morales E, Praga M, Andres A, Morales JM. Transplant Proc; 2009 Nov 15; 41(6):2435-7. PubMed ID: 19715944 [Abstract] [Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group. Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208 [Abstract] [Full Text] [Related]
7. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L. Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508 [Abstract] [Full Text] [Related]
8. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients. Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT. Transplant Proc; 2005 Mar 15; 37(2):693-6. PubMed ID: 15848504 [Abstract] [Full Text] [Related]
9. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen. Lisik W, Schoenberg L, Lasky RE, Kahan BD. Transplant Proc; 2007 Dec 15; 39(10):3086-92. PubMed ID: 18089328 [Abstract] [Full Text] [Related]
10. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation. Tellis V, Schechner R, Mallis M, Rosegreen S, Glicklich D, Moore N, Greenstein S. Transplant Proc; 2005 Mar 15; 37(2):906-8. PubMed ID: 15848571 [Abstract] [Full Text] [Related]
11. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients. Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M. Transplant Proc; 2005 Mar 15; 37(2):839-42. PubMed ID: 15848550 [Abstract] [Full Text] [Related]
12. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery. Hsu HJ, Tian YC, Chen YC, Lai BC, Fang JT, Yang CW, Wu MS. Ren Fail; 2008 Mar 15; 30(3):303-6. PubMed ID: 18350450 [Abstract] [Full Text] [Related]
13. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW. Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948 [Abstract] [Full Text] [Related]
14. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant. Hymes LC, Warshaw BL. Pediatr Transplant; 2005 Aug 15; 9(4):520-2. PubMed ID: 16048606 [Abstract] [Full Text] [Related]
15. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C. Pediatr Transplant; 2006 Jun 15; 10(4):474-8. PubMed ID: 16712606 [Abstract] [Full Text] [Related]
16. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V, Campbell-Lee SA, Tzvetanov IG, Sankary HN, Kaplan B, Benedetti E, Oberholzer J. Transplantation; 2009 Jan 27; 87(2):268-73. PubMed ID: 19155983 [Abstract] [Full Text] [Related]
17. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T, Sevmiş S, Karakayali H, Moray G, Haberal M. Transplant Proc; 2008 Jan 27; 40(1):123-5. PubMed ID: 18261564 [Abstract] [Full Text] [Related]
18. [Clinical study of application of sirolimus with dose-reduced or discontinued cyclosporine A for prevention of acute rejection after kidney transplantation]. Lin J, Tang YW, Sun W, DU LD, Tian Y. Zhonghua Wai Ke Za Zhi; 2009 Sep 01; 47(17):1319-21. PubMed ID: 20092728 [Abstract] [Full Text] [Related]
19. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience. Li JT, Danguilan RA, Cabanayan-Casasola CB, Talusan-Tomacruz Y, Ona ET. Transplant Proc; 2008 Sep 01; 40(7):2211-3. PubMed ID: 18790195 [Abstract] [Full Text] [Related]
20. A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection. Mathew TH, Van Buren C, Kahan BD, Butt K, Hariharan S, Zimmerman JJ. J Clin Pharmacol; 2006 Jan 01; 46(1):76-87. PubMed ID: 16397287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]